Novartis AG
Common Stock · GBP · XETRA
Price
£118.33
Cap
£195.43B
Earnings
—
30d Trend
+4.2%
19% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 67×Macro 0.99 (−1%)=66
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Long-term compounder with 8.1% yield
BRAIN47'S ASSESSMENT
I rate Novartis AG at 66/100 — a STRONG reading on the Brain47 Signal. The strongest factor is quality at 78/100. I classify this as a income position with the strongest thesis on a long-term horizon.
PAST PERFORMANCE
1 MONTH
+4.3%
3 MONTHS
-6.6%
12 MONTHS
—
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Long-term compounder with 8.1% yield. Quality (78) and low-risk profile are the primary strengths. Historical volatility is normal at 19%. I classify this as an income position — the 8.1% yield combined with low volatility makes it suitable for income generation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.